Geonzon, Mary Grace B.

HRN: 23-88-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/12/2023
10/19/2023
IV
500mg
TID
PARASITIC INFECTION
Waiting Final Action 
10/13/2023
CEFTRIAXONE 1G (VIAL)
10/13/2023
10/19/2023
IVT
2g
OD
Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: